Given the fact that the IL-18 receptor is expressed on MAIT cells (36), and that serum IL-18 is known to be increased in MS patients (23), as well as present in MS CNS lesions (23–37), we set out to investigate whether MAIT cells were activated by IL-18. The gene discussed is IL18; the disease is myeloid sarcoma.